MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment.

about

MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment.

Item

http://www.wikidata.org/entity/Q55364931

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment.

@en

MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment.

@nl

type

Item

label

MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment.

@en

MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment.

@nl

prefLabel

MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment.

@en

MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment.

@nl

P1476

MATLAB®-based fitting method to evaluate survival fractions after multimodal treatment

@en

P2093

Jolanta Marzec

http://www.w3.org/2001/XMLSchema#string

Lukasz Marzec

http://www.w3.org/2001/XMLSchema#string

Peter Martus

http://www.w3.org/2001/XMLSchema#string

P2860

The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways.

Clonogenic assay of cells in vitro.

Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data.

Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review).

The linear-quadratic formula and progress in fractionated radiotherapy.

Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase 1 inhibition.

The first James Kirk memorial lecture. What next in fractionated radiotherapy?

The radioresponsiveness of human tumours and the initial slope of the cell survival curve.

The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction.

P304

36-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CTRO.2018.03.003

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Arndt-Christian Müller

Daniel Zips

P577

2018-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29928704

http://www.w3.org/2001/XMLSchema#string

P932

6008626

http://www.w3.org/2001/XMLSchema#string